Krystal, Up 7.43% on COVID-19 (Camostat) Theme Surge

On the 11th, the COVID-19 (Camostat) theme showed strength by rising 3.01% compared to the previous day, while Crystal, a stock attracting attention as a related company, surged 7.43% compared to the previous day. Crystal is known as a company specializing in new drug development, including arthritis treatments and novel antibiotics.

[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to provisional data compiled at 13:36, Crystal is experiencing a large net sell-off by foreigners, who sold 22,000 shares.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Crystal’s quant financial score is 13.32 points, ranking 3rd in the quant financial ranking within the COVID-19 (Camostat) related theme. This can be interpreted as Crystal having relatively low investment attractiveness from a financial perspective. On the other hand, Daewoong Pharmaceutical ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.